Yeast Infection Market Research Report- Forecast till 2027

Yeast Infection Market Information: By Pathogen (Candida Albicans, Candida Glabrata, Candida Rugosa, Others), By Types (Vaginal Yeast Infection, Skin Yeast Infection, Throat Yeast Infection, Others), By Treatment (Drug Treatments, Surgery), By End Users (Hospital, Clinics, Ambulatory Centers) - Forecast Till 2027

ID: MRFR/Pharma/2884-HCR | February 2021 | Region: Global | 203 Pages         

Brief TOC

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis

6 Global Yeast Infection Market, by Pathogens

6.1 Introduction

6.2 Candida albicans

6.3 Candida glabrata

6.4 Candida rugosa

6.5 Others

7 Global Yeast Infection Market, by Types

7.1 Introduction

7.2 Vaginal Yeast Infection

7.3 Skin Yeast Infection

7.4 Throat Yeast Infection

7.5 Others

8 Global Yeast Infection Market, by Treatment

8.1 Drug Treatment

8.2 Cream

8.3 Ointment

8.4 Tablet

8.5 Suppository

8.2 Surgery

9 Global Yeast Infection Market, by End User

9.1 Introduction

9.2 Hospital

9.3 Clinics

9.4 Ambulatory Centers

9.5 Others

10 Global Yeast Infection Market by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Republic of Korea

10.4.5 Australia

10.4.6 Rest of Asia-Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Scynexis

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Synmedic Laboratories

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Merck & Co., Inc.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Astellas

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Bayer AG

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Abbott

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Novartis AG

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical Industry

14 Appendix

Yeast Infection Market

Yeast Infection Market is expected to grow at a CAGR of 6.45% during the forecast period 2022-2030

Segmentation

By Pathogen Candida Albicans Candida Glabrata Candida Rugosa
By Types Vaginal Yeast Infection Skin Yeast Infection Throat Yeast Infection
By Treatment Drug Treatments Surgery
By End Users Hospital Clinics Ambulatory Centers

Key Players

  • Sanofi
  • Astellas Pharma Inc
  • Synmedic Laboratories
  • Astra Zeneca
  • Synmedic Laboratories
  • Allergan
  • Pfizer Inc
  • Brundavan Laboratories
  • Merck & Co.Inc

Drivers

  • Increasing prevalence of autoimmune diseases
  • Continuously increasing geriatric population
Speak to Analyst Request a Free Sample

Yeast Infection Market Overview 


The yeast infection market is assumed to grow by 5.2% in the forecast period. Candidiasis is an infection that is also known as yeast and fungus infection. It is a component that is already in the human body. In some conditions, it can cause infection due to changes in the immunity level of the body. The yeast infection can occur in the skin, mouth and belly areas. Vaginal yeast infection is common among the women population. It is an infection that can cause rashes, swelling, and redness, itching and burning. Low immunity, lack of hygiene, and lifestyle diseases can lead to yeast infection. 


A healthy body has a proper level of yeast cells. The yeast infection market is witnessing immense demand due to its prevalence. The market has plenty of segments that propel the profitability in the forecast period. Heat treatment includes ointment, drug, cream tablet, surgery and more. All these products create more opportunities for the yeast infection market. The wide range of products and treatments offer plenty of choices to the customers. As per yeast infection treatment market analysis these factors will bring favourable changes.


Covid analysis 


The outbreak of the covid 19 virus is causing financial instability in global markets. Private sectors have damaging effects due to the pandemic. The economic burden on the healthcare sector is tremendous in this period. The supply chain, developments and production of drugs is affected. Treatment for the yeast infection is affected during this period. Infections are non-essential medical treatments.


 According to an orthopaedic medical journal, most of the doctors are deployed for covid patient care. However, the research in the clinical drug market is growing. It will lead to plenty of developments in the yeast infection drug market. These developments will bring favourable changes in the yeast infection market. The product line of the yeast infection market will be wide in the upcoming years. The vaginal yeast infection market will witness the highest growth rate. 


Market dynamics 



  • Crucial market dynamics 


The prevalence of the autoimmune disease is a crucial driver for the yeast infection market. Autoimmune diseases can lead to plenty of problems in the patients. The normal yeast level of the body can turn into an infection in an autoimmune condition. To control the yeast infection the need for drugs, ointment, cream and treatment is essential. Due to eating habits and lifestyle changes many individuals have an autoimmune disorder. The growth of this disease leads to more adoption of yeast infection treatment. It is a crucial factor as maximum demand comes from this population. Furthermore, an increase in yeast infection among individuals is another factor driving demand. The emerging new types of treatment are another factor rising yeast infection market demand. The use of antibiotics is causing more yeast infection issues in individuals. 


Most of the women taking antibiotics are prone to vaginal infection. As per the US medical journal, it is the most common infection in the state. With the prevalence of yeast infection, the growth rate of the market is surging. The growing number of HIV is another factor that drives demand in the yeast infection market. HIV is a serious disease that causes plenty of infections in the human body. HIV patients do not have immunity to manage the yeast infection. Effective yeast infection treatment is necessary for such individuals. Due to this, the treatment of yeast infection regions such as North America and the Asia Pacific are increasing. Also, the investments in this region for the yeast infection market are growing rapidly. All these crucial divers of the market will lead to a more expansion rate. 



  • Market growth opportunities 


The upcoming product launches of the market will lead to plenty of growth in the forecast period. Innovative product launches of the market will attract more end users. Also, the yeast infection treatment market applications increase due to new products. The key players are creating a formula with effective components to cure yeast infections effectively. This ongoing development in the market will offer plenty of choices for the customers to choose from.


Key players in the market are developing drugs that breakdowns infectious cells in the body. All these factors will lead to the massive growth of the yeast infection market. The rising opioid in several regions is raising the growth prospects for the yeast infection market. Further, the players of the market are increasing their strategies. The manufacturing of yeast infection drugs is surging in the forecast period. The launch of a wide range of therapies for vaginal infection is another factor that will enhance growth opportunities. All these factors will contribute to the high revenue rates of the market. 



  • The market restraint 


The increasing adoption of alternative therapies for yeast infection is a crucial restraint. Some of the alternative therapies are more efficient than the market offers. The competitors of the market are launching dietary supplements that are an effective cure for the yeast infection market.


It is a mixture of effective enzymes that treat yeast infection. More awareness about alternative therapies poses a challenge to the yeast infection market. The rising production and demand for alternative therapies can cause a declining effect on the yeast infection market. 



  • The market challenges 


The side effects of yeast infection drugs are a challenge in the market. Most of the clinical drugs come with mild side effects. These side effects can vary from person to person. Headache, heartburn, dizziness, upset stomach and abdominal pain are the side effects of the drug.


Antifungal treatment is made with strong components to stop the spread of infection. Due to this, the side effects are in some individuals can worsen. Due to the fear of side effects, the demand rate can decline. Poor knowledge about the use, benefits and effects of yeast infection treatment can hamper the overall demand. 



  • Cumulative growth analysis 


The yeast infection market trends remains stable in the forecast period. The factors that increase growth are the prevalence of autoimmune diseases. It is a condition that leads to more infections in the patients. The yeast infection treatment and drugs have high demand from the end-user. The increasing rate of HIV conditions leads to more yeast infection market growth.


Due to these conditions, the immunity level in patients is low. All these drive exceptional demand for the yeast infection market. The new types of yeast lead to more research in the market. With research, the innovation in the market is constantly increasing. However, side effects and alternative therapies are restraining factors. With new product launches the market growth rate is substantial in the forecast period. 



  • Value chain analysis 


North America holds the largest yeast infection market shares. The rise of new yeast infections is leading to high market demand. Further, it is a region with the highest number of vaginal cases. Due to this, yeast infection treatment and drugs have a massive need. The advanced health infrastructure in North America is the major reason for the high growth in the yeast infection market.


Most of the hospitals have a separate sector for yeast infection treatment. Further, it is a region that offers exceptional reimbursement for yeast infection treatments. North America is a region that has favourable factors for yeast infection market growth. With the highest investment, the market will invest exceptional revenue rates. 


Segment overview 


By pathogens 



  • Candida drugs 

  • Candida alb cans 

  • Candida drugs 


By types 



  • Throat yeast infection 

  • Vaginal yeast infection 

  • Skin yeast infection 


By treatment 



  • Surgery 

  • Drug treatment 

  • Suppository 

  • Cream 

  • Tablet 

  • Ointment 


By geography 



  • Asia pacific 

  • Europe 

  • North America 

  • The Middle East and Africa 


Competitive landscape 


The competition in the yeast infection market is increasing. With alternative therapies, the market is rapidly improving. The key players are making drug development by using effective components.


Innovation and product variation are the key factors that enable more developments. Market expansion, acquisition and partnership are the key strategies in the competitive landscape.  


Regional analysis 


The yeast infection regional market is diversified into Asia Pacific, Europe and North America. The presence of the key players in North America is causing more demand. Also, the cases of yeast infection are surging every year in this region. It leads to plenty of developments and innovations in the market.


Europe is another largest yeast infection market with immense demand. The vaginal yeast infection cases are higher in this region. Also, there are favourable factors that increase growth opportunities in Europe. The launch of new treatment will lead to market expansion in Europe. Also, Asia Pacific is a region with moderate demand. The fungal infection is higher leading to more demand. 


The key players of the yeast infection market are 



  • Sanofi

  • Astellas Pharma Inc

  • Synmedic Laboratories

  • Astra Zeneca

  • Synmedic Laboratories

  • Allergan

  • Pfizer Inc

  • Brundavan Laboratories

  • Merck & Co., Inc

  • Corden Pharma


Recent developments 



  1. The key players of the market are increasing the production of vaginal yeast infection drugs.  



  1. The awareness about yeast infection treatment is rising in the middle and other emerging markets. 


Report overview 



  1. Market overview highlights 

  2. Analysis based upon COVID 19

  3. Explanation upon the Market Dynamics

  4. Value chain analysis

  5. Market segmentation overview

  6. The regional analysis

  7. Competitive landscape analysis

  8. Recent Developments



Report Scope:
Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   2017-2023: 5.2%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Pathogen, Types, Treatment, and End users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Scynexis (US), Synmedic Laboratories (India), Merck & Co., Inc. (US), Astellas (Japan), Bayer AG (Germany), Mentis Pharma Ltd. (India), Abbott (US), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi (France), ALLERGAN (Ireland), AstraZeneca (UK)
  Key Market Opportunities   New treatment methods
  Key Market Drivers

  • Increasing prevalence of autoimmune diseases
  • Continuously increasing geriatric population
  • Increasing number of patients suffering from HIV


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The projected CAGR is 5.2% for the forecast period (2018-2023).

    The players are Synmedic Laboratories (India), Scynexis (US), Astellas (Japan), Bayer AG (Germany), Merck & Co., Inc. (US), Abbott (US), Mentis Pharma Ltd. (India), Sanofi (France), Novartis AG (Switzerland), Pfizer Inc. (US), AstraZeneca (UK), ALLERGAN (Ireland), and others.

    What are the end users in the Yeast Infection Market?

    Yeast Infection Market has types like a skin yeast infection, throat yeast infection, vaginal yeast infection, and others.

    Americas would lead the Yeast Infection Market.